Aberrant extra-vascular expression of VE-cadherin has been observed in metastasis associated with Vasculogenic Mimicry (VM); we have recently shown that in VM prone (VM+) tumor cells VE-cadherin is mainly in the form of pVEcadherin in Y658 allowing an increased plasticity that potentiates VM development.
, consistent with the in vitro observations that these patterns are generated exclusively by highly invasive tumor cells (Maniotis et al., 1999) . ECs express various members of the cadherin superfamily, in particular vascular endothelial (VE-) cadherin (VEC), which is the main adhesion receptor of endothelial adherent junctions. Aberrant extra-vascular expression of VE-cadherin has been observed in certain cancer types associated with VM (Hendrix et al., 2001 ). VE-PTP (vascular endothelial protein tyrosine phosphatase) is an endothelial receptor-type phosphatase whose name was coined for its prevalence to the bind to VE-cadherin (Nawroth et al., 2002) . VE-PTP poise endothelial barrier through helping homotypic VE-cadherin to keep at minimum basal endothelial permeability (Wessel et al., 2014) . Knockdown of VE-PTP increases endothelial permeability and leukocyte extravasation. VE-PTP also counterbalances the effects of permeability-increasing mediators such as VEGF, which increase endothelial permeability and leukocyte trafficking, by dephosphorylating VEcadherin at Tyr658 and Tyr685, leading to stabilization of VE-cadherin junctions (Orsenigo et al., 2012; Wallez et al., 2007) .
While studies have focused on the connection between VE-PTP and VE-cadherin in ECs no reports have focused about the role of VE-PTP in VM. We have recently
shown that phospho-VEcadherin is highly expressed in VM+ cells and facilitates their pseudoendothelial behaviour by favouring p120/kaiso-dependent gene regulation (Delgado-Bellido et al., 2018 ). In the current study, we have elucidated a mechanism linking VE-PTP expression to induction of VM in metastatic melanoma through its association with VE-Cadherin/p120 consequent implications in the stability of the complex that promote autophagy. These results place VE-PTP as a dynamic component of VM transformation of melanoma cells owing to its ability retain/safeguard VE-cadherin from being degraded by autophagy in aggressive cells.
Results and discussion

VE-PTP expression is essential for VE-cadherin stability and to form VM
Aberrant extra-vascular expression of VE-cadherin has been observed in certain cancer types associated with VM and we have previously shown that most of theVE-cadherin present in VM+ melanoma cells is phosphorylated form in Y658 (Delgado-Bellido et al., 2018 ). In the current study, we focused in the role of the phosphatase VE-PTP and its interaction with VE-cadherin and its consequences in VM development. Total VE-cadherin and VE-PTP expression was measured in different melanoma cell lines from either cutaneous (C8161, C81-61) or uveal (MUM 2B, MUM 2C) origin as shown in Fig.1A (protein) and b (mRNA). Recently, our group reported that human malignant melanoma cells have a constitutively high expression of pVE-cadherin at position Y658, pV-EC-cadherin Y658 is a target of focal adhesion kinase (FAK) and forms a complex with p120-catenin and the transcriptional repressor Kaiso in the nucleus (Delgado-Bellido et al., 2018) .
We also have shown that FAK inhibition enabled Kaiso to suppress the expression of its target genes and enhanced Kaiso recruitment to KBS-containing promoters (CCND1 and WNT 11). We observed that silencing of VE-PTP induced a significant reduction of CCND1 and WNT 11 (Kaiso-dependent genes) ( Figure 1C) and disrupted VM formation ( Fig 1D) suggesting that VE-PTP was also involved in the intracellular dynamic of VE-cadherin resulting in the regulation of kaisodependent genes. To evaluate the correlation between the levels of VE-PTP and VE-cadherin we performed a western after siVE-PTP in MUM 2B ( Fig 1E) and found an almost complete disappearance of VE-cadherin and phoshoVE-cadherin suggesting that VE-PTP was involved in VE-cadherin stability and needed for phosphoVE-Cadherin to reach the nucleus, as indirectly suggested the results obtained in Fig 1C and Figure 2A ) compared with HUVECs ( Fig 2B) .
Surprisingly, the presence of p120-catenin in complex with VE-PTP was much higher in MUM2B cells as compared to HUVEC cells (Figures 2B and 2C) suggesting that VE-PTP might be involved in the control of p120-catenin phosphorylation status in melanoma cells. To analyze the possible impact of p120 on VE-cadherin stability in MUM2B, we performed a cytosol-nucleus subfractionation assay after silencing p120 and we found that p120 protect the stability of VE-cadherin (Fig 2D) . Finally, we performed a coIP of p120 after siVE-PTP in MUM 2B cells, and we observed that binding of VE-cadherin to VE-PTP was lost and resulted in increased global tyrosine phosphorylation of p120, suggesting that VE-PTP safeguard of VE-Cadherin/p120 binding in VM + cells ( Fig   2F) and p120-catenin is likely to be a substrate for VE-PTP. These results are compatible with the increased phosphop120 (as result of VE-PTP inactivation)
being responsible of complex dissociation to initiate ve-cadherin proteolysis.
VE-Cad/VE-PTP complex dissociation enhanced autophagy
In view of elevated expression of VE-PTP in aggressive melanoma cells and his association with VE-Cadherin/p120 association, we investigated the possible implication of autophagy in these models. To dissect the mechanism leading to VECadherin degradation after the inhibition of VE-PTP, we treat MUM 2B with proteasome inhibitor lactacystin and did not prevent the degradation of VECadherin after VE-PTP disabling ( Figure 3A ). Macroautophagy (referred to simple as "autophagy") is a homeostatic "self-eating" pathway that has been conserved among eukaryotic cells. Is a lysosomal-associated process which intracellular components, small portions of cytosol or receives chaperone-associated cargoes are engulfed in double-membrane vesicles, called autophagosomes, to be degraded with lysosomal hydrolyses (Dikic and Elazar, 2018) . Recently, different studies report that the formation of VM was promoted by bevacizumab-induced autophagy in GSCs, which was associated with tumor resistance to antiangiogenic therapy through high expression of VEGFR-2 (9) . In our setting, inhibition of the fusion of autophagosomes and lysosomes with chloroquine suppressed the degradation of VE-cadherin after siVE-PTP ( Fig 3A) . Even more, the levels of the mTOR substrate p-p70 (as a readout od mTOR activity and autophagy status) decreased in the MUM 2B K.O cells ( Figure 3B ), suggesting that VE-cadherin/VE-PTP complex might be restraining autophagy. We then performed an electron microscopy experiment in MUM 2B and C8161 in siVE-PTP or MUM 2B knockout for VE-cadherin; we shown an enhanced autophagic morphology after the VE-PTP silencing or VE-cadherin knockout cells, suggesting that the presence of either protein out of the complex triggered autophagy. To confirm the implication of autophagy on VE-cadherin degradation, we perfomed an experiment to quantify autophagosomes formation under the same conditions described above after transfection LC3-GFP, and we observed that autophagosomes (LC3-GFP puncta)
increased following silencing of VE-PTP in both MUM 2B and C8161 VM + cells ( Fig   3D) . By analysing the cBioPortal database, a platform of 48333 tumour samples, we found that high mRNA levels of PTPRB were inversely associated with the expression of two key genes involved in autophagy, LAMP1 and ATG7 in uveal melanoma (figure S1B), suggesting that in patients this interaction might be relevant to determine autophagy features of the tumor. and C) and the loss of this complex (after siVE-PTP silencing) leads to p120-catenin increased phosphorylation and VE-cadherin degradation. Globally these results shed light to a new mechanism to control VM through the balance between VE-PTP/VE-cadherin .
Materials and methods
Reagents and antibodies
The following reagents were used: Chloroquine 20 
Cell lines
Human melanoma cells MUM 2B, MUM 2C, C8161, and C81-61 were grown in RPMI medium supplemented with 10% fetal bovine serum, 2 mM of L-glutamine, and 1% penicillin/streptomycin (PAA laboratories). Human umbilical vein endothelial cells (HUVEC) were grown in endothelial cells growth medium-2 (EGM-2) (Lonza). All cells were cultured at 37 °C and 5% CO2 in incubator cells.
In vitro angiogenesis assay
The effect of siVE-PTP on the formation of tube-like structures in Matrigel (BD 
Gene editing
MUM2B knockout (ko) cells for the VE-Cad gene were generated using the CRISPR-Cas9 technology. Five different sgRNAs were designed using the Zhang Lab Optimized CRISPR design tool and cloned into the pL-CRISPR.EFS.GFP which was purchased from the Addgene public repository (#57818). sgRNA guides were validated in HEK293T Cells using the GeneArt Genomic Cleavage Detection Kit (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions.
Lentiviral particles for the best two sgRNAs in terms of allelic disruption (GGCAGGCGCCCGATGTGGCG and GATGATGCTCCTCGCCACATC).
Transfection of small interfering siRNA:
Cultured cells were transiently transfected with an irrelevant siRNA (5′-CCUACAUCCCGAUCGAUGAUG-3′) 50nM. siVE-PTP: 5′-GACAGUAUGAGGUGGAAGU -3′, 50nM, sip120: 5′-GGATCACAGTCACCTTCTA -3′, 50nM, were transfected for 48 hours using JetPrime (Polyplus transfection)
according to the recommendations.
Immunobloting, immunoprecipitation, subfractionation cytosol-nucleus
For simple coimmunoprecipitation, cells were lysed in lysis buffer ( 50 mM Tris/HCl ph 8, 120 mM NaCl, 0,1 % NP-40, 1mM EDTA, 10 mM NaF, 1 mM Na3VO4 and supplemented with a protease inhibitor cocktail (1 tablets to 10 ml of lysis buffer, Roche) for 30 minutes at 4ºC. Lysates were cleared by 13.000 rpm centrifugation for 10 minutes at 4ºC and incubated over night at 4ºC with respective antibodies.
Consequently, the next day IP lysates were incubated for 2 hours at 4ºC with 50 µl of of Dynabeads™ Protein G for Immunoprecipitation (ThermoFischer). Dynabeads were washed 3 times with low salt 120 mM lysis buffer and 2 times with high salt 300 mM lysis buffer. All lysates were separated by dodecyl sulfate-polyacrylamide (7,5%, Biorad) gel electrophoresis and transferred to PVDF membrane (Pall laboratory) by semi-wet blotting.
Accordingly with the article of Maxie Rockstroh et al in 2011, for subfractionation cytosol-nucleus , cells were lysed in lysis buffer (250 mM sucrose, 50 mM Tris-HCl ph 7,4, 5 mM MgCl2, 1 mM Na3VO4, 0,25 % NP-40 and supplemented with a protease inhibitor cocktail (1 tablets to 10 ml of lysis buffer, Roche) for 10 minutes at 4ºC,lysated were centrifuged at 500 g for 5 minutes, supernatant was considerate cytosolic fraction, pellet was resuspended in buffer 2 (1M sucrose, 50 mM Tris-HCl ph 7,4, 5 mM MgCl2) and centrifuged at 3000 g for 5 minutes, supernatant was discarded. Pellet was resuspended in nuclear buffer (20 mM TrisHCl ph 7,4, 0,4 M NaCl, 15% glycerol, 1,5% Triton X-100) for 45 minutes at 4ºC in agitation. This lysate were centrifuged at 5000 g for 5 minutes, supernatant was considered nuclear fraction.
Electron microscopy
The MUM 2B extracted were washed with PBS, prefixed for 30 min in a fixation solution (0.1 M cacodilate buffer pH 7.4 and osmium tetraoxyde) for 60 min at 4 °C. immunoprecipitation of p120 revealed after inhibition of VE-PTP produce a high increase onto p120 phosphorylation and decrease in the union of VE-cadherin. have a high union with VE-PTP and VE-cadherin, d) cytosol-nucleus subfracionation with scb and sip120 shown that the stability of VE-cadherin as well the phosphorylation of Y658 is p120-dependent, e) finally, immunoprecipitation of p120 revealed after inhibition of VE-PTP produce a high increase onto p120 
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